| DC Field | Value | Language |
|---|
| dc.contributor.author | Osipova, O. A. | - |
| dc.contributor.author | Zhernakova, N. I. | - |
| dc.contributor.author | Pokrovskii, M. V. | - |
| dc.contributor.author | Gorelik, S. G. | - |
| dc.contributor.author | Plaksina, K. G. | - |
| dc.date.accessioned | 2018-04-24T08:46:22Z | - |
| dc.date.available | 2018-04-24T08:46:22Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.citation | Influence mechanisms of mineralocorticoid receptor antagonist (spironolactone) among elderly patients with chronic heartfailure against ischemic disease / O.A. Osipova [и др.] // International Journal of Advanced Biotechnology and Research. - 2018. - Vol.9, N1.-P. 1061-1065. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/21811 | - |
| dc.description.abstract | It was determined that a significant positive dynamics of TNF-synthesis suppression by 67.0% (p 0.0001) was established in the 4th group of patients taking combined therapy with the blocker of mineralocorticoid receptors with spironolactone | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | cardiology | ru |
| dc.subject | heart disease | ru |
| dc.subject | heart failure | ru |
| dc.subject | chronic heart failure | ru |
| dc.subject | elderly patients | ru |
| dc.subject | TNF-α | ru |
| dc.subject | the blocker of mineralocorticoid receptors | ru |
| dc.subject | spironolactone | ru |
| dc.title | Influence mechanisms of mineralocorticoid receptor antagonist (spironolactone) among elderly patients with chronic heartfailure against ischemic disease | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
